Insider Trading April 10, 2026 07:10 AM

Interim CFO of Coda Octopus Sells $28,410 of Stock as Company Posts Better-Than-Expected Q1

Form 4 shows sale of 2,256 shares on March 19, 2026; Coda Octopus reported EPS and revenue beats for first quarter of fiscal 2026

By Maya Rios CODA
Interim CFO of Coda Octopus Sells $28,410 of Stock as Company Posts Better-Than-Expected Q1
CODA

Gayle Michelle Jardine, interim chief financial officer of Coda Octopus Group, Inc. (NASDAQ: CODA), recorded a sale of 2,256 shares on March 19, 2026, for $28,410, according to a Form 4 filing. The transaction leaves Jardine with 2,500 shares directly held. The sale coincides with a year-to-date share price surge and first-quarter fiscal 2026 results that topped expectations on both earnings and revenue.

Key Points

  • Interim CFO Gayle Michelle Jardine sold 2,256 shares on March 19, 2026, at $12.5935 per share, totaling $28,410; Jardine now directly owns 2,500 shares.
  • CODA shares have risen over 101% in the past year and were trading at $12.38; InvestingPro flags the stock as overvalued relative to its Fair Value.
  • Coda Octopus beat expectations in Q1 FY2026 with EPS of $0.08 versus $0.06 forecast and revenue of $6.71 million versus $6.23 million expected.

Gayle Michelle Jardine, serving as interim chief financial officer at Coda Octopus Group, Inc. (NASDAQ: CODA), disclosed a sale of company stock in a Form 4 filed with the Securities and Exchange Commission. The filing records that Jardine sold 2,256 shares on March 19, 2026, at a per-share price of $12.5935, producing proceeds of $28,410.

Following the disposition, Jardine is reported to directly own 2,500 shares of Coda Octopus Group. The SEC filing is the source for the transaction details.


The insider sale takes place against the backdrop of a strong run for CODA shares over the last year. The stock has risen by more than 101% over the past 12 months and is trading at $12.38. Separately, InvestingPro analysis referenced in the filing indicates the stock appears overvalued relative to its calculated Fair Value and is listed among names the service classifies as Most Overvalued. The investment service notes that a comprehensive Pro Research Report is available for CODA as part of its coverage of more than 1,400 U.S. equities.


Corporate results released for the first quarter of fiscal 2026 showed Coda Octopus beating analyst expectations. The company reported earnings per share of $0.08, above the consensus forecast of $0.06, a difference the filing quantifies as a 33.33% beat relative to expectations. Revenue for the quarter came in at $6.71 million versus forecasts of $6.23 million, a 7.7% surprise in the company’s favor.

Those quarterly figures are described as a strong start to the fiscal year. The filing notes there were no accompanying updates about mergers or acquisitions, and there were no analyst upgrades or downgrades reported in connection with the earnings release.


Market participants and investors tracking insider activity, valuation signals and quarterly performance will likely continue to monitor subsequent filings and company disclosures for further developments. The filing and the company’s reported results provide the factual basis for the items above; no additional corporate actions or analyst moves were reported alongside these disclosures.

Risks

  • Valuation concern - InvestingPro analysis categorizes CODA as overvalued relative to its Fair Value, posing potential valuation risk for equity investors.
  • Limited insider ownership post-transaction - Jardine’s direct holdings decreased to 2,500 shares, which may reduce insider-aligned equity exposure.
  • Uncertainty around corporate actions and analyst response - there were no updates on mergers or acquisitions and no analyst upgrades or downgrades reported with the quarterly results.

More from Insider Trading

SailPoint Chief Accounting Officer Disposes $82.7K in Stock Amid Price Weakness Apr 10, 2026 Goldman Sachs Executes Market-Making Purchases in Sweetgreen, Acquires $3.3M Stake Apr 9, 2026 Rockwell Automation SVP Executes $484,375 Stock Sale Under 10b5-1 Plan Apr 9, 2026 Relay Therapeutics CFO Disposes $257K in Shares as Stock Trades Near Yearly Peak Apr 9, 2026 Jabil SVP Sells $288,000 of Stock as Company Posts Strong Q2 and Raises Guidance Apr 9, 2026